Navigation Links
ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis
Date:12/7/2009

"We are very excited to obtain the world's first approval for a surgical sutureless heart valve. This initial offering in the Enable platform is an important first step in bringing disruptive technology to the traditional surgical market. Ultimately, we envision the Enable platform facilitating minimally invasive procedures for patients with conventional surgical indications," stated Michael Dale, President and CEO of ATS Medical. "Additionally, by reducing procedural time and the trauma incurred with current conventional surgical procedures, we believe Enable may also become a viable solution for certain patients who are currently considered too sick for surgery."

Commercialization of the Enable valve will commence with a controlled market release at select surgical centers in Europe. These sites will serve as "Centers of Excellence" where surgeons throughout Europe will be trained in the state-of-the-art techniques used for implanting the Enable valve and will be instrumental in the development and launch of future generations of the ATS 3f Enable platform. Release of the second generation Enable is expected in the latter half of 2010.

The Company is continuing to develop sutureless tissue valve technology for use in beating heart procedures based in part on the characteristics of the next generation of Enable valves. First-in-man studies of these novel technologies are targeted for 2010. Commercialization of a beating heart solution could occur within one to two years thereafter. A valve compatible in beating heart procedures would enlarge the Company's market opportunity by providing a solution for those patients who are poor candidates to endure conventional surgery.

About ATS Medical

ATS Medical, Inc. is dedicated to 'Advancing The Standards' of cardiac surgery through the development, manufacturing and marketing of innovative products and services for the treatment of structural heart dise
'/>"/>

SOURCE ATS Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Alberta companies delivering new products to the health & medical marketplace
2. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
3. Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures
4. Gamida Cell Announces Feasibility Study With Weill Cornell Medical College
5. New Jerseys Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development
6. PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT
7. Aethlon Medical to Present at LD MICRO Conference on December 3, 2009
8. China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia
9. ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ
10. Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence
11. Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... VILLAGE, Nev. , July 28, 2015  PDL ... ) today announced that the Company will release its ... June 30, 2015, on Wednesday, August 5, 2015, after ... and webcast that day at 4:30 p.m. Eastern Time ... to the call will be available via the webcast ...
(Date:7/28/2015)... July 21, 2015 ... the addition of the "Analysis of the ... their offering. Globally, flow cytometry remains ... cell proliferation, cancer, and stem cells. But the ... primarily because of demand from underdeveloped nations to ...
(Date:7/28/2015)... , July 28, 2015 Tauriga Sciences, ... diversified life sciences company, today announced that its stockholders ... of common stock of the Company from 1,000,000,000 to ... July 27, 2015 at the Law Offices of Nixon ... the Special Meeting, there were 480,655,929 shares of common ...
(Date:7/28/2015)... KING OF PRUSSIA, Pa. , July 28, 2015 ... the U.S. Food and Drug Administration has accepted for ... novel investigational recombinant factor VIII single-chain (rVIII-SingleChain) for the ... rVIII-SingleChain met all primary endpoints. ... by deficient or defective factor VIII; nearly all affected ...
Breaking Biology Technology:PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3
... Oct. 13 This afternoon, Fraunhofer USA, Inc.,s ... its first laboratory, a PV module innovation facility ... Ambassador Klaus Scharioth and Massachusetts Energy Secretary Bowles. ... , The new PV module laboratory enables research, ...
... and MIAMI, Oct. 13 The Alpha-1 Foundation announced ... study how genetic variations in the alpha-1 antitrypsin (AAT) ... with AAT deficiency. The inherited condition causes emphysema and ... infusion therapy -- known as augmentation therapy -- minimizes ...
... 13 Advanced Life Sciences Holdings, Inc. (OTC ... the discovery, development and commercialization of novel drugs ... respiratory diseases, today announced that it will present ... in San Francisco. , (Logo: http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO ...
Cached Biology Technology:Fraunhofer CSE Opens First Laboratory in Cambridge, MA 2Fraunhofer CSE Opens First Laboratory in Cambridge, MA 3The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 2The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 3The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. 4Advanced Life Sciences to Present at 8th Annual BIO Investor Forum 2
(Date:7/7/2015)... , June 30, 2015 ... announced the addition of the "Capacitive Fingerprint ... To this date, fingerprint sensing technology ... and fingerprint sensors are well developed. This patent ... technology. The domain of capacitive fingerprint ...
(Date:7/2/2015)... 2, 2015 Fingerprint Cards has received ... and FPC1155 from the distributor World Peace Industrial Group (WPI), ... in Asia . Deliveries are planned to ... be used by smartphone manufacturers in Asia ... the communicated revenue guidance of approximately 2,200 MSEK for 2015. ...
(Date:6/25/2015)... 25, 2015 According to ... (Swipe & Area), Technology, Material (Optical Prism, Piezoelectric, ... Security & Others) & Geography - Global Forecast ... said market is expected to reach $14,500.07 Million ... Browse 76 market Tables and 109 ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
... Some animals, it seems, are going on a diet, ... are reactions to rapidly rising temperatures due to global ... University,s Department of Zoology, who has been measuring the ... where climate change is most extreme. , Changes are ...
... New research from the Hood Center for Children and Families ... light on the significant potential negative impact that food product ... The study, which appears in the current edition of the ... placements" for food, beverage, and food retail establishments that are ...
... LA JOLLA, CA--Scientists at The Scripps Research Institute have discovered ... standard treatment for sheep and cattle infected with liver fluke. ... in combating river blindness, a tropical disease that is the ... , The study is scheduled for publication in an advance, ...
Cached Biology News:Animals cope with climate change at the dinner table 2New study examines the impact on children of food product placements in the movies 2New study examines the impact on children of food product placements in the movies 3Scripps research team reveals how an old drug could have a new use for treating river blindness 2Scripps research team reveals how an old drug could have a new use for treating river blindness 3Scripps research team reveals how an old drug could have a new use for treating river blindness 4
... vinyl curtains or parting strip ... support frame to form a ... meets cleanliness to Class 10/ISO ... units, lights, and ionizers are ...
... The first high-density serum biomarker chip to ... proteins. An antibody chip containing 120 human ... that enables biomarker discovery scientists to study ... benefits of therapy and the likelihood of ...
... a highly sensitive reagent for the detection ... purified form of recombinant E. coli phosphate-binding ... is sensitive to changes in its environment.How ... Sensor is rapid and tight (Kd ~ ...
... modular benchtop fume hood ventilates ... safe indoor release of exhaust. ... organic contaminants. Configurations are available ... options include final HEPA filter, ...
Biology Products: